Downregulation of two isoforms of ubiquitin carboxyl‐terminal hydrolase isozyme L1 correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones

Abstract

Proteomic differential display analysis was performed on human renal cell carcinoma cell SN12C clones having different metastatic potentials by using 2-DE and LC-MS/MS. The SN12C cell clones were SN12C parent cell line, SN12C-clone 2, SN12C-clone 4, and SN12C-PM6. The SN12C parent cell line was established from an HRCC surgical specimen. SN12C-clone 4 has lower, and SN12C-clone 2 and SN12C-PM6 have higher metastatic potential than SN12C parent cells. We found eight protein spots whose expression level was different between low metastatic clones and high metastatic clones. The protein expression of three appeared to be higher in high metastatic clones than low metastatic clones, and that of other five protein spots appeared to be lower in high metastatic clones than low metastatic clones. These spots were selected, digested and analyzed by LC-MS/MS analysis, and they were identified by peptide sequencing tag. In high metastatic potential clones, two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) were downregulated. These results suggest that UCH-L1 expression seems to be associated with the metastatic potential of HRCC SN12C cell clones.

HIV gp41 Engages gC1qR on CD4+ T Cells to Induce the Expression of an NK Ligand through the PIP3/H2O2 Pathway

“…Briefly, protein lysates were mixed with IEF buffer supplemented with 1% IPG pH 3–7 buffer (GE Healthcare), 12 µL/ml Destreak reagent (GE Healthcare) plus bromophenol blue. Samples were added to 18 cm 3–10 NL strips (GE Healthcare) and treated as previously described [47]. SDS-Page was performed on 10% polyacrylamide, and gels were either stained with Imperial Protein Stain (Pierce) or with the PlusOne Silver Staining Kit (GE Healthcare), according to the manufacturer's instructions.…”

Downregulation of ER60 Protease Inhibits Cellular Proliferation by Inducing G1/S Arrest in Breast Cancer Cells In Vitro

“…However, ER60 protease expression has also been reported to be partially downregulated or even absent in cancers such as gastric adenocarcinoma (Leys et al, 2007), squamous cell esophageal carcinoma (Qi et al, 2008;Ayshamgul et al, 2011), cervical carcinoma (Mehta et al, 2008), and renal cell carcinoma (Tanaka et al, 2008). Some investigators have attributed this observation to ER60 protease being a key component for antigen presentation by MHC-I molecules during immune surveillance (Garbi et al, 2007;Chapman and Williams, 2010), and therefore a lower expression would facilitate immune evasion by cancer cells (Seliger et al, 2001;Dunn et al, 2006;Seliger et al, 2010).…”

Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry

“…Ief was performed in six steps which were: rehydration for 10 h (no voltage), 0 to 500 V for 4 h, 500 to 1000 V for 1 h, 1000 to 8000 V for 4 h, 8000 V for 20 min, and the final phase of 500 V from 20000 to 30000 Vh. The Ipg strips were equilibrated as described previously and then transferred onto the gels, run at 200 V. SDS-PAgE was performed on a precast polyacrylamide gel with a linear concentration gradient of 5-20% (Bio-Rad) (15).…”